{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:03:40Z","timestamp":1793361820779,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Science and Technology Support Program of the 12th Five-Year Plan of China","award":["2012BAI12B03"],"award-info":[{"award-number":["2012BAI12B03"]}]},{"name":"National Science and Technology Support Program of the 12th Five-Year Plan of China","award":["2012BAI12B03"],"award-info":[{"award-number":["2012BAI12B03"]}]},{"name":"Beijing Platform Construction of Basic Research and Clinical Translation of Nervous System Injury","award":["PXM2020_026280_000002"],"award-info":[{"award-number":["PXM2020_026280_000002"]}]},{"name":"Beijing Platform Construction of Basic Research and Clinical Translation of Nervous System Injury","award":["PXM2020_026280_000002"],"award-info":[{"award-number":["PXM2020_026280_000002"]}]},{"name":"Beijing Natural Science Foundation","award":["7252005"],"award-info":[{"award-number":["7252005"]}]},{"name":"Beijing Natural Science Foundation","award":["7252005"],"award-info":[{"award-number":["7252005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-025-02883-6","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T07:21:27Z","timestamp":1746775287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Multiplatform molecular analyses reveal two molecular subgroups of NF2-related schwannomatosis vestibular schwannomas with distinct tumour microenvironment and therapeutic vulnerabilities"],"prefix":"10.1007","volume":"149","author":[{"given":"Fu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Fei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Guang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Hui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pi-Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"2883_CR1","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/ng.3688","volume":"48","author":"S Agnihotri","year":"2016","unstructured":"Agnihotri S, Jalali S, Wilson MR, Danesh A, Li M, Klironomos G et al (2016) The genomic landscape of schwannoma. Nat Genet 48:1339\u20131348. https:\/\/doi.org\/10.1038\/ng.3688","journal-title":"Nat Genet"},{"key":"2883_CR2","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1038\/s41467-021-22691-2","volume":"12","author":"MR Alkaslasi","year":"2021","unstructured":"Alkaslasi MR, Piccus ZE, Hareendran S, Silberberg H, Chen L, Zhang Y et al (2021) Single nucleus RNA-sequencing defines unexpected diversity of cholinergic neuron types in the adult mouse spinal cord. Nat Commun 12:2471. https:\/\/doi.org\/10.1038\/s41467-021-22691-2","journal-title":"Nat Commun"},{"key":"2883_CR3","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","volume":"373","author":"AR Asthagiri","year":"2009","unstructured":"Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z et al (2009) Neurofibromatosis type 2. Lancet 373:1974\u20131986. https:\/\/doi.org\/10.1016\/S0140-6736(09)60259-2","journal-title":"Lancet"},{"key":"2883_CR4","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41467-023-42762-w","volume":"15","author":"TF Barrett","year":"2024","unstructured":"Barrett TF, Patel B, Khan SM, Mullins RDZ, Yim AKY, Pugazenthi S et al (2024) Single-cell multi-omic analysis of the vestibular schwannoma ecosystem uncovers a nerve injury-like state. Nat Commun 15:478. https:\/\/doi.org\/10.1038\/s41467-023-42762-w","journal-title":"Nat Commun"},{"key":"2883_CR5","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1038\/s41416-024-02646-2","volume":"130","author":"P Baruah","year":"2024","unstructured":"Baruah P, Mahony C, Marshall JL, Smith CG, Monksfield P, Irving RI et al (2024) Single-cell RNA sequencing analysis of vestibular schwannoma reveals functionally distinct macrophage subsets. Br J Cancer 130:1659\u20131669. https:\/\/doi.org\/10.1038\/s41416-024-02646-2","journal-title":"Br J Cancer"},{"key":"2883_CR6","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/s41467-023-37226-0","volume":"14","author":"C Chiasson-MacKenzie","year":"2023","unstructured":"Chiasson-MacKenzie C, Vitte J, Liu CH, Wright EA, Flynn EA, Stott SL et al (2023) Cellular mechanisms of heterogeneity in NF2-mutant schwannoma. Nat Commun 14:1559. https:\/\/doi.org\/10.1038\/s41467-023-37226-0","journal-title":"Nat Commun"},{"key":"2883_CR7","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.neuron.2023.02.030","volume":"111","author":"SL Coffin","year":"2023","unstructured":"Coffin SL, Durham MA, Nitschke L, Xhako E, Brown AM, Revelli JP et al (2023) Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1. Neuron 111:915. https:\/\/doi.org\/10.1016\/j.neuron.2023.02.030","journal-title":"Neuron"},{"key":"2883_CR8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/neuonc\/nou317","volume":"17","author":"R Dewan","year":"2015","unstructured":"Dewan R, Pemov A, Kim HJ, Morgan KL, Vasquez RA, Chittiboina P et al (2015) Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas. Neuro Oncol 17:566\u2013573. https:\/\/doi.org\/10.1093\/neuonc\/nou317","journal-title":"Neuro Oncol"},{"key":"2883_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3171\/2012.3.JNS111649","volume":"117","author":"MS Dirks","year":"2012","unstructured":"Dirks MS, Butman JA, Kim HJ, Wu T, Morgan K, Tran AP et al (2012) Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors. J Neurosurg 117:109\u2013117. https:\/\/doi.org\/10.3171\/2012.3.JNS111649","journal-title":"J Neurosurg"},{"key":"2883_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41436-019-0598-7","volume":"22","author":"DG Evans","year":"2020","unstructured":"Evans DG, Hartley CL, Smith PT, King AT, Bowers NL, Tobi S et al (2020) Incidence of mosaicism in 1055 de novo NF2 cases: much higher than previous estimates with high utility of next-generation sequencing. Genet Med 22:53\u201359. https:\/\/doi.org\/10.1038\/s41436-019-0598-7","journal-title":"Genet Med"},{"key":"2883_CR11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/jmg.2006.047753","volume":"44","author":"DG Evans","year":"2007","unstructured":"Evans DG, Ramsden RT, Shenton A, Gokhale C, Bowers NL, Huson SM et al (2007) Mosaicism in neurofibromatosis type 2: an update of risk based on uni\/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification. J Med Genet 44:424\u2013428. https:\/\/doi.org\/10.1136\/jmg.2006.047753","journal-title":"J Med Genet"},{"key":"2883_CR12","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noaa284","volume":"23","author":"C Forde","year":"2021","unstructured":"Forde C, King AT, Rutherford SA, Hammerbeck-Ward C, Lloyd SK, Freeman SR et al (2021) Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution. Neuro Oncol 23:1113\u20131124. https:\/\/doi.org\/10.1093\/neuonc\/noaa284","journal-title":"Neuro Oncol"},{"key":"2883_CR13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jmedgenet-2017-104519","volume":"54","author":"D Halliday","year":"2017","unstructured":"Halliday D, Emmanouil B, Pretorius P, MacKeith S, Painter S, Tomkins H et al (2017) Genetic Severity Score predicts clinical phenotype in NF2. J Med Genet 54:657\u2013664. https:\/\/doi.org\/10.1136\/jmedgenet-2017-104519","journal-title":"J Med Genet"},{"key":"2883_CR14","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1038\/s41388-020-1374-5","volume":"39","author":"DL Helbing","year":"2020","unstructured":"Helbing DL, Schulz A, Morrison H (2020) Pathomechanisms in schwannoma development and progression. Oncogene 39:5421\u20135429. https:\/\/doi.org\/10.1038\/s41388-020-1374-5","journal-title":"Oncogene"},{"key":"2883_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gigascience\/gix024","volume":"6","author":"J Huang","year":"2017","unstructured":"Huang J, Liang X, Xuan Y, Geng C, Li Y, Lu H et al (2017) A reference human genome dataset of the BGISEQ-500 sequencer. Gigascience 6:1\u20139. https:\/\/doi.org\/10.1093\/gigascience\/gix024","journal-title":"Gigascience"},{"key":"2883_CR16","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/neuonc\/noad201","volume":"26","author":"Z Huo","year":"2024","unstructured":"Huo Z, Wang Z, Luo H, Maimaitiming D, Yang T, Liu H et al (2024) Single-cell transcriptomes reveal the heterogeneity and microenvironment of vestibular schwannoma. Neuro Oncol 26:444\u2013457. https:\/\/doi.org\/10.1093\/neuonc\/noad201","journal-title":"Neuro Oncol"},{"key":"2883_CR17","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/neuonc\/nos146","volume":"14","author":"MA Karajannis","year":"2012","unstructured":"Karajannis MA, Legault G, Hagiwara M, Ballas MS, Brown K, Nusbaum AO et al (2012) Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol 14:1163\u20131170. https:\/\/doi.org\/10.1093\/neuonc\/nos146","journal-title":"Neuro Oncol"},{"key":"2883_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/neuonc\/not150","volume":"16","author":"MA Karajannis","year":"2014","unstructured":"Karajannis MA, Legault G, Hagiwara M, Giancotti FG, Filatov A, Derman A et al (2014) Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol 16:292\u2013297. https:\/\/doi.org\/10.1093\/neuonc\/not150","journal-title":"Neuro Oncol"},{"key":"2883_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/jmg.40.2.109","volume":"40","author":"L Kluwe","year":"2003","unstructured":"Kluwe L, Mautner V, Heinrich B, Dezube R, Jacoby LB, Friedrich RE et al (2003) Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas. J Med Genet 40:109\u2013114. https:\/\/doi.org\/10.1136\/jmg.40.2.109","journal-title":"J Med Genet"},{"key":"2883_CR20","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3171\/2020.3.JNS193230","volume":"134","author":"D Lewis","year":"2021","unstructured":"Lewis D, Donofrio CA, O\u2019Leary C, Li KL, Zhu X, Williams R et al (2021) The microenvironment in sporadic and neurofibromatosis type II-related vestibular schwannoma: the same tumor or different? A comparative imaging and neuropathology study. J Neurosurg 134:1419\u20131429. https:\/\/doi.org\/10.3171\/2020.3.JNS193230","journal-title":"J Neurosurg"},{"key":"2883_CR21","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/neuonc\/noy177","volume":"21","author":"D Lewis","year":"2019","unstructured":"Lewis D, Roncaroli F, Agushi E, Mosses D, Williams R, Li KL et al (2019) Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannoma. Neuro Oncol 21:314\u2013325. https:\/\/doi.org\/10.1093\/neuonc\/noy177","journal-title":"Neuro Oncol"},{"key":"2883_CR22","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41467-023-40408-5","volume":"15","author":"SJ Liu","year":"2024","unstructured":"Liu SJ, Casey-Clyde T, Cho NW, Swinderman J, Pekmezci M, Dougherty MC et al (2024) Epigenetic reprogramming shapes the cellular landscape of schwannoma. Nat Commun 15:476. https:\/\/doi.org\/10.1038\/s41467-023-40408-5","journal-title":"Nat Commun"},{"key":"2883_CR23","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/B978-0-444-52902-2.00054-0","volume":"115","author":"SK Lloyd","year":"2013","unstructured":"Lloyd SK, Evans DG (2013) Neurofibromatosis type 2 (NF2): diagnosis and management. Handb Clin Neurol 115:957\u2013967. https:\/\/doi.org\/10.1016\/B978-0-444-52902-2.00054-0","journal-title":"Handb Clin Neurol"},{"key":"2883_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00401-020-02230-x","volume":"141","author":"S Mansouri","year":"2021","unstructured":"Mansouri S, Suppiah S, Mamatjan Y, Paganini I, Liu JC, Karimi S et al (2021) Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. Acta Neuropathol 141:101\u2013116. https:\/\/doi.org\/10.1007\/s00401-020-02230-x","journal-title":"Acta Neuropathol"},{"key":"2883_CR25","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1227\/01.NEU.0000255340.26027.53","volume":"60","author":"D Mathieu","year":"2007","unstructured":"Mathieu D, Kondziolka D, Flickinger JC, Niranjan A, Williamson R, Martin JJ et al (2007) Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates. Neurosurgery 60:460\u2013468. https:\/\/doi.org\/10.1227\/01.NEU.0000255340.26027.53. (discussion 468-470)","journal-title":"Neurosurgery"},{"issue":"4147\u20134164","key":"2883_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2021.07.040","volume":"81","author":"F Meng","year":"2021","unstructured":"Meng F, Yu Z, Zhang D, Chen S, Guan H, Zhou R et al (2021) Induced phase separation of mutant NF2 imprisons the cGAS-STING machinery to abrogate antitumor immunity. Mol Cell 81(4147\u20134164):e4147. https:\/\/doi.org\/10.1016\/j.molcel.2021.07.040","journal-title":"Mol Cell"},{"key":"2883_CR27","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/neuonc\/noad066","volume":"25","author":"SR Plotkin","year":"2023","unstructured":"Plotkin SR, Allen J, Dhall G, Campian JL, Clapp DW, Fisher MJ et al (2023) Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma. Neuro Oncol 25:1498\u20131506. https:\/\/doi.org\/10.1093\/neuonc\/noad066","journal-title":"Neuro Oncol"},{"key":"2883_CR28","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1200\/JCO.19.01367","volume":"37","author":"SR Plotkin","year":"2019","unstructured":"Plotkin SR, Duda DG, Muzikansky A, Allen J, Blakeley J, Rosser T et al (2019) Multicenter, prospective, phase II and biomarker study of high-dose bevacizumab as induction therapy in patients with neurofibromatosis type 2 and progressive vestibular schwannoma. J Clin Oncol 37:3446\u20133454. https:\/\/doi.org\/10.1200\/JCO.19.01367","journal-title":"J Clin Oncol"},{"key":"2883_CR29","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1097\/MAO.0b013e3181eb328a","volume":"31","author":"SR Plotkin","year":"2010","unstructured":"Plotkin SR, Halpin C, McKenna MJ, Loeffler JS, Batchelor TT, Barker FG 2nd (2010) Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients. Otol Neurotol 31:1135\u20131143. https:\/\/doi.org\/10.1097\/MAO.0b013e3181eb328a","journal-title":"Otol Neurotol"},{"key":"2883_CR30","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1097\/MAO.0000000000000239","volume":"35","author":"SR Plotkin","year":"2014","unstructured":"Plotkin SR, Merker VL, Muzikansky A, Barker FG 2nd, Slattery W 3rd (2014) Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patients. Otol Neurotol 35:e50-56. https:\/\/doi.org\/10.1097\/MAO.0000000000000239","journal-title":"Otol Neurotol"},{"key":"2883_CR31","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","volume":"24","author":"SR Plotkin","year":"2022","unstructured":"Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO et al (2022) Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation. Genet Med 24:1967\u20131977. https:\/\/doi.org\/10.1016\/j.gim.2022.05.007","journal-title":"Genet Med"},{"key":"2883_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00401-016-1583-8","volume":"132","author":"A Schulz","year":"2016","unstructured":"Schulz A, B\u00fcttner R, Hagel C, Baader SL, Kluwe L, Salamon J et al (2016) The importance of nerve microenvironment for schwannoma development. Acta Neuropathol 132:289\u2013307. https:\/\/doi.org\/10.1007\/s00401-016-1583-8","journal-title":"Acta Neuropathol"},{"key":"2883_CR33","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/jmedgenet-2015-103050","volume":"52","author":"SM Stivaros","year":"2015","unstructured":"Stivaros SM, Stemmer-Rachamimov AO, Alston R, Plotkin SR, Nadol JB, Quesnel A et al (2015) Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2. J Med Genet 52:557\u2013562. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103050","journal-title":"J Med Genet"},{"issue":"1159\u20131175","key":"2883_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.07.043","volume":"178","author":"J Suh","year":"2019","unstructured":"Suh J, Romano DM, Nitschke L, Herrick SP, DiMarzio BA, Dzhala V et al (2019) Loss of Ataxin-1 potentiates Alzheimer\u2019s pathogenesis by elevating cerebral BACE1 transcription. Cell 178(1159\u20131175):e1117. https:\/\/doi.org\/10.1016\/j.cell.2019.07.043","journal-title":"Cell"},{"key":"2883_CR35","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1136\/jmedgenet-2020-106973","volume":"58","author":"Y Teranishi","year":"2021","unstructured":"Teranishi Y, Miyawaki S, Hongo H, Dofuku S, Okano A, Takayanagi S et al (2021) Targeted deep sequencing of DNA from multiple tissue types improves the diagnostic rate and reveals a highly diverse phenotype of mosaic neurofibromatosis type 2. J Med Genet 58:701\u2013711. https:\/\/doi.org\/10.1136\/jmedgenet-2020-106973","journal-title":"J Med Genet"},{"key":"2883_CR36","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/neuonc\/noad121","volume":"25","author":"EA Williams","year":"2023","unstructured":"Williams EA, Ravindranathan A, Gupta R, Stevers NO, Suwala AK, Hong C et al (2023) Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs. Neuro Oncol 25:2221\u20132236. https:\/\/doi.org\/10.1093\/neuonc\/noad121","journal-title":"Neuro Oncol"},{"key":"2883_CR37","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/ncb3496","volume":"19","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Meng F, Chen S, Plouffe SW, Wu S, Liu S et al (2017) Hippo signalling governs cytosolic nucleic acid sensing through YAP\/TAZ-mediated TBK1 blockade. Nat Cell Biol 19:362\u2013374. https:\/\/doi.org\/10.1038\/ncb3496","journal-title":"Nat Cell Biol"},{"key":"2883_CR38","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/path.5908","volume":"257","author":"F Zhao","year":"2022","unstructured":"Zhao F, Chen Y, Li SW, Zhang J, Zhang S, Zhao XB et al (2022) Novel patient-derived xenograft and cell line models for therapeutic screening in NF2-associated schwannoma. J Pathol 257:620\u2013634. https:\/\/doi.org\/10.1002\/path.5908","journal-title":"J Pathol"},{"key":"2883_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-018-2812-x","author":"F Zhao","year":"2018","unstructured":"Zhao F, Wang B, Yang Z, Zhou Q, Li P, Wang X et al (2018) Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation. J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-018-2812-x","journal-title":"J Neurooncol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02883-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-025-02883-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02883-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T07:21:28Z","timestamp":1746775288000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-025-02883-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["2883"],"URL":"https:\/\/doi.org\/10.1007\/s00401-025-02883-6","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"47"}}